359 related articles for article (PubMed ID: 30144461)
1. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
Luthra P; Naidoo J; Pietzsch CA; De S; Khadka S; Anantpadma M; Williams CG; Edwards MR; Davey RA; Bukreyev A; Ready JM; Basler CF
Antiviral Res; 2018 Oct; 158():288-302. PubMed ID: 30144461
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion.
Luthra P; Aguirre S; Yen BC; Pietzsch CA; Sanchez-Aparicio MT; Tigabu B; Morlock LK; García-Sastre A; Leung DW; Williams NS; Fernandez-Sesma A; Bukreyev A; Basler CF
mBio; 2017 Apr; 8(2):. PubMed ID: 28377530
[TBL] [Abstract][Full Text] [Related]
3. Classical swine fever virus non-structural protein 4A recruits dihydroorotate dehydrogenase to facilitate viral replication.
Zhao B-q; Chen J; Chen J-X; Cheng Y; Zhou J-f; Bai J-s; Mao D-y; Zhou B
J Virol; 2024 Jun; 98(6):e0049424. PubMed ID: 38757985
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY
J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975
[TBL] [Abstract][Full Text] [Related]
5. [Stimulation of the antiviral innate immune response by pyrimidine biosynthesis inhibitors: a surprise of phenotypic screening].
Vidalain PO; Lucas-Hourani M; Helynck O; Tangy F; Munier-Lehmann H
Med Sci (Paris); 2015 Jan; 31(1):98-104. PubMed ID: 25658737
[TBL] [Abstract][Full Text] [Related]
6. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
7. Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis.
Yang CF; Gopula B; Liang JJ; Li JK; Chen SY; Lee YL; Chen CS; Lin YL
Emerg Microbes Infect; 2018 Nov; 7(1):187. PubMed ID: 30459406
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting pyrimidine biosynthesis impairs Peste des Petits Ruminants Virus replication through depletion of nucleoside pools and activation of cellular immunity.
Jin L; Li Y; Pu F; Wang H; Zhang D; Bai J; Shang Y; Ma Z; Ma XX
Vet Microbiol; 2021 Sep; 260():109186. PubMed ID: 34333402
[TBL] [Abstract][Full Text] [Related]
9. A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication.
Luthra P; Liang J; Pietzsch CA; Khadka S; Edwards MR; Wei S; De S; Posner B; Bukreyev A; Ready JM; Basler CF
Antiviral Res; 2018 Feb; 150():193-201. PubMed ID: 29294299
[TBL] [Abstract][Full Text] [Related]
10. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis.
Hoffmann HH; Kunz A; Simon VA; Palese P; Shaw ML
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5777-82. PubMed ID: 21436031
[TBL] [Abstract][Full Text] [Related]
11. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.
Pryke KM; Abraham J; Sali TM; Gall BJ; Archer I; Liu A; Bambina S; Baird J; Gough M; Chakhtoura M; Haddad EK; Kirby IT; Nilsen A; Streblow DN; Hirsch AJ; Smith JL; DeFilippis VR
mBio; 2017 May; 8(3):. PubMed ID: 28465426
[TBL] [Abstract][Full Text] [Related]
12. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
[TBL] [Abstract][Full Text] [Related]
13. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
Nelson EV; Pacheco JR; Hume AJ; Cressey TN; Deflubé LR; Ruedas JB; Connor JH; Ebihara H; Mühlberger E
Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
[TBL] [Abstract][Full Text] [Related]
14. Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro.
Gong M; Yang Y; Huang Y; Gan T; Wu Y; Gao H; Li Q; Nie J; Huang W; Wang Y; Zhang R; Zhong J; Deng F; Rao Y; Ding Q
Antiviral Res; 2021 Oct; 194():105161. PubMed ID: 34391783
[TBL] [Abstract][Full Text] [Related]
15. A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle.
Martin S; Chiramel AI; Schmidt ML; Chen YC; Whitt N; Watt A; Dunham EC; Shifflett K; Traeger S; Leske A; Buehler E; Martellaro C; Brandt J; Wendt L; Müller A; Peitsch S; Best SM; Stech J; Finke S; Römer-Oberdörfer A; Groseth A; Feldmann H; Hoenen T
Genome Med; 2018 Aug; 10(1):58. PubMed ID: 30081931
[TBL] [Abstract][Full Text] [Related]
16. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
Fanunza E; Frau A; Corona A; Tramontano E
Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
[TBL] [Abstract][Full Text] [Related]
17. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
18. Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
Menicucci AR; Jankeel A; Feldmann H; Marzi A; Messaoudi I
mBio; 2019 May; 10(3):. PubMed ID: 31138743
[TBL] [Abstract][Full Text] [Related]
19. Potent antiviral activity of brequinar against the emerging Cantagalo virus in cell culture.
Schnellrath LC; Damaso CR
Int J Antimicrob Agents; 2011 Nov; 38(5):435-41. PubMed ID: 21840180
[TBL] [Abstract][Full Text] [Related]
20. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]